CU6
Clarity Pharmaceuticals Ltd
🇦🇺 ASX
📦 LOGISTICS
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 128.35%
Annual Growth
3 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
61
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. The company is headquartered in Eveleigh, New South Wales. The company went IPO on 2021-08-25. The firm is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. The company is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. The company has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.
📈 Performance
Price History
+410.71%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$7.15
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CU6
61
📊 Total Capital Earnings
$418K
🔃 Average investment frequency
27 weeks
💵 Average investment amount
$2,612
⏰ Last time a customer invested in CU6
8 hours
CU6 investor breakdown
💵 Income of investors
More than 200k
9%
150k - 200k
100k - 150k
19%
50k - 100k
48%
Less than 50k
21%
👶 Age of investors
18 - 25
26 - 34
36%
35 - 90
59%
🙋 Legal gender of investors
Female
54%
Male
46%
Pearlers who invest in CU6 also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.85%
📊 Share price
$100.90 AUD
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
🧱 MATERIALS
💸 FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.86%
📊 Share price
$129.54 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
18.86%
📊 Share price
$57.74 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The firm is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).
🙌 Performance (5Yr p.a)
261.00%
📊 Share price
$22.41 AUD
🧬 BIOTECHNOLOGY
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
24.88%
📊 Share price
$45.04 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Want more shares? Try these...
Cue Energy Resources Ltd. engages in the exploration, development and production of oil and gas. The company is headquartered in Melbourne, Victoria. In Australia, it has interests in three production assets, Mereenie, Palm Valley, and Dingo Fields, situated in the Amadeus Basin within the onshore Northern Territory. The Mereenie field produces gas which is transported through the Northern Gas pipeline to serve the Eastern Australia gas market. The Palm Valley field is 100 kilometers west of Alice Springs and produces gas, which is transported through the Amadeus and Northern Gas pipeline and sold into the Northern Territory and Eastern Australia gas markets. The Dingo field produces gas, which is processed at the Brewer Estate processing facility located near Alice Springs. In New Zealand, it holds a 5% interest Petroleum Mining Permit (PMP) 38160, which contains the Maari and Manaia producing oilfields. In Indonesia, it holds interests in Mahato PSC and Sampang PSC.
🙌 Performance (5Yr p.a)
-3.20%
📊 Share price
$0.10 AUD
⚡️ ENERGY
CUF
CuFe Ltd. operates as an exploration company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2005-10-13. The firm is focused on iron ore projects and exposure to key strategic metals, copper and lithium. The company has interests in various projects and tenements prospective for copper, gold and iron ore, all located in Australia. Its projects include Tennant Creek Copper Project, JWD Deposit and Yarram Iron Ore Project. The company operates and holds a 55% interest in the Tennant Creek Project. The company also operates and holds a 50% interest in the Yarram Iron Ore JV. The Yarram Iron Ore Project is located approximately 110 kilometers (km) from Darwin Port in the Northern Territory. The company also has an agreement to acquire two exploration licenses, including E80/5925 and P45/3061. E80/5925 is located in the West Arunta region, approximately 620 km south of Kununurra. P45/3061 is located in the Tambourah region of the Pilbara, approximately 90 km south of Pilgangoora and Wodgina Lithium Operations. The company also has exploration projects in the Bryah Basin.
🙌 Performance (5Yr p.a)
-10.00%
📊 Share price
$0.01 AUD
⛏️ MINING
Careteq Ltd. engages in the development, design, and commercialization of assisted-living technology products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-10. The firm is using its early-mover advantage in the Assistive Living Technology sector to revolutionize aged and disability care across the globe. Its brands include Sofihub, TEQ-FallsAlert and Embedded Health Solutions (EHS). The Sofihub brand is an advanced adaptive care technology that gives people of all ages and abilities the freedom to live independently, while reducing their reliance on family or professional careers. Sofihub has developed a suite of intelligent adaptive technology that enables the aged and at-risk members of society to live independently. TEQ-FallsAlert powered by Sofihub employs radar technology that provides continuous non-invasive monitoring, allowing care resources to be managed efficiently. EHS helps health care workers with professional knowledge and advice to help prevent incidents of medicine-related harm.
📊 Share price
$0.01 AUD
🩺 HEALTH CARE
Cettire Ltd. is an online luxury goods retailer, which engages in luxury personal items such as clothing, shoes, bags, and accessories via their website. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-18. The firm is engaged in offering a selection of in demand personal luxury goods via its Website, cettire.com. The company has access to an extensive catalogue of more than 2,500 luxury brands and 500,000 products of clothing, shoes, bags, and accessories. The company sells a range of products from over 500 designers, which include a range of women's and men's wear from brands, such as Prada, Gucci, Saint Laurent, Balenciaga, and Valentino, among others. The firm's product categories include clothing, shoes, bags, and accessories. Its clothing category offers activewear, coats, jackets, jeans, knitwear, pants, and various others. Its shoes category offers boots, espadrilles, lace-up shoes, loafers, and various others. The Company’s bags category offers bag accessories, belt bags, clutch bags, crossbody bags and various others. The firm also offers accessories, such as belts, glasses, gloves, hats, and various others.
📊 Share price
$1.38 AUD
🛍️ CONSUMER